Abstract

World Health Organization studies have demonstrated that 80% of the world’s population depends on medicinal plants for their primary health care. This has prompted increased efforts to the adoption and integration of herbal practices in health systems. This study soughts to answer the question whether Piliostigma thonningii has antitubercular, antibacterial, antifungal and cytotoxic activity. Antimicrobial activity was investigated by disc diffusion and micro dilution techniques. Antituberculous activity was investigated using the BACTEC MGIT 960 system while cytotoxicity was evaluated by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay on Vero cells. Phytochemicals were profiled using standard chemical procedures. A major output of our study is the methanolic fractions which yielded the best antituberculous activity (minimum inhibitory concentration [MIC] of 12.5 µg/ml), the highest antibacterial activity with zones of inhibition of 20.3 mm and MIC of 31.25 µg/ml (Staphylococcus aureus), 18.3 mm and MIC of 62.5 µg/ml (Methicillin Resistant S. Aureus, MRSA), 14 mm and MIC of 125 µg/ml (Escherichia coli), 13.3 mm and MIC of 31.25 (Shigella sonnei) and 13 mm against (Candida albicans), all within the acceptable toxicity limit (CC50 >500 µg/ml). The activity could be attributed to various phytochemicals that tested positive especially terpenoids. Important is its high activity against MRSA, S. aureus, E. coli, S. sonnei, C. albicans and Mycobacterium tuberculosis which are health challenge due to drug resistance and sources of community and nosocomial infections. To the best of our knowledge, this is the first report exploring the antituberculous activity of P. thonningii and thence a major addition in search of new safe antituberculous drug leads.   Key words: Antibacterial activity, cytotoxicity, antifungal activity, antibacterial activity, terpenoids, phytochemicals, Piliostigma thonningii, herbal medicine.

Highlights

  • There is an increased and concerted efforts to the adoption and integration of traditional medicine and medical practices referred to as complementary or/and alternative medicine in both developing and developedJ

  • This study first sought to identify whether the plant bark extract had any general antibacterial activity by mimicking the indigenous extraction methods

  • A major output of the current study is the identification of the methanolic fractions which yielded the best antituberculous activity (MIC of 12.5 μg/ml) as well as the highest antibacterial activity (with zones of inhibition of 20.3 mm and MIC of 31.25 μg/ml (S. aureus), 18.3 mm and MIC of 62.5 μg/ml (MRSA), 14 mm and MIC of 125

Read more

Summary

Introduction

There is an increased and concerted efforts to the adoption and integration of traditional medicine and medical practices referred to as complementary or/and alternative medicine in both developing and developedJ. Countries in their health system (World Health Organization [WHO], 2005) This is after studies by WHO have demonstrated that 80% of the world’s population depends on medicinal plants for their primary health care (Mothana et al, 2008; Gupta et al, 2010). It has been reported that in many African countries, various parts of the plant (root, bark, seed, and fruit) are used to treat wounds, ulcers, gastric and heart pain, gingivitis, and as an antipyretic (Silva et al, 1997; Maroyi, 2011, 2013). Certain compounds (alkaloids, flavonoids, saponins and tannins) isolated from some of its parts have been reported to bear anti-inflammatory, analgesic and antibacterial activities (Paiva et al, 2010; Akinpelu and Obuotor, 2000)

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call